Acute mountain sickness

Search with Google Search with Bing
Information
Disease name
Acute mountain sickness
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00326703 Completed N/A Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort October 2002 April 2003
NCT00559832 Completed N/A Prevention of Acute Mountain Sickness by Intermittent Hypoxia March 2006 July 2007
NCT00603122 Completed N/A Acclimatization Mechanisms During Ascent to 7500m March 2005 December 2005
NCT00627965 Completed Phase 4 Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness March 2003 February 2008
NCT00664001 Completed Phase 3 Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness March 2003 December 2003
NCT03390335 Completed N/A Decompression Tables for Diving at Altitude February 13, 2018 October 29, 2021
NCT03424226 Completed Phase 1 Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages August 4, 2018 September 30, 2018
NCT03561675 Completed Phase 4 Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years May 15, 2018 August 31, 2019
NCT03828474 Completed Phase 1 Sickness Evaluation at Altitude With Acetazolamide at Relative Doses August 9, 2019 September 29, 2019
NCT04111263 Completed N/A Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude October 6, 2019 November 5, 2022
NCT05023941 Completed Phase 4 Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide December 1, 2021 August 30, 2022
NCT05734716 Completed Phase 4 Colorado-Oregon Altitude Study February 17, 2021 January 1, 2023
NCT05798416 Completed N/A Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude February 15, 2023 April 29, 2023
NCT06310642 Completed Phase 4 Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness May 20, 2021 March 13, 2023
NCT01418157 Completed Phase 4 A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent August 2011 October 2011
NCT01436383 Completed N/A Oxidative Stress in Hypobaric Hypoxia March 2005 February 2010
NCT01468194 Completed N/A Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude July 2011 November 2011
NCT01522326 Completed N/A Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness March 1, 2012 March 30, 2017
NCT01536288 Completed Phase 2 Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness October 2010 May 2011
NCT01665781 Completed Phase 4 Erythropoietin in the Prevention of Acute Mountain Sickness August 2012 March 2013
NCT01794130 Completed The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude July 2011 July 2011
NCT01842906 Completed N/A Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) October 2013 October 2014
NCT01902758 Completed Phase 2/Phase 3 Drug Combination on Exercise Performance at High Altitude August 2013 August 2013
NCT02604173 Completed Phase 3 Altitude Sickness Prevention and Efficacy of Comparative Treatments August 2016 September 2016
NCT02811016 Completed Phase 1 Inhaled Budesonide and Acute Mountain Sickness June 2016 October 2016
NCT03154645 Completed Phase 1 Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy August 12, 2017 October 1, 2017
NCT03270787 Completed Phase 1/Phase 2 Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness June 24, 2016 July 13, 2017
NCT06145113 Not yet recruiting N/A The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness March 10, 2024 August 10, 2024
NCT06039475 Recruiting RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY July 1, 2023 November 30, 2023
NCT05733338 Recruiting N/A The Effects of Intermittent Hypoxia on Acute Hypoxic Injury March 1, 2023 April 30, 2023
NCT06450899 Recruiting Phase 2 Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness August 2024 July 2025
NCT06393998 Recruiting N/A CO2 Supplement for Treatment of Acute Mountain Sickness June 7, 2024 August 15, 2024
NCT03956472 Terminated N/A Alternative Treatments in Acute Mountain Sickness June 17, 2017 July 31, 2019
NCT01698619 Unknown status Hemodynamic Changes in Altitude Adaptation August 2012 December 2012
NCT01565603 Unknown status Sleep and Cerebral Responses to High Altitude July 2011 October 2012
NCT00886912 Unknown status N/A Training in Hypoxia to Prevent Acute Mountain Sickness June 2008 October 2009
MedGen concept unique identifier (MedGen Concept name)
C0238284
MedGen unique identifier (MedGen Concept name)
536790